The North America CRISPR and CRISPR-Associated (Cas) Genes Market is witnessing remarkable momentum as gene-editing technologies continue to reshape the future of healthcare, biotechnology, and l...
The North American biotechnology and life sciences sector continues to play a significant role in advancing gene-editing technologies. Increasing investments in genomic research, precision medici...